Gowlings Logo Life Sciences News @ Gowlings
July 28, 2010

Life Sciences News @ Gowlings image
  Use Twitter?    Follow Gowlings news on Twitter

Deal Fever Is No Rare Disease
http://blogs.wsj.com/source/2010/07/28/deal-fever-is-no-rare-disease/

Gel for decayed teeth 'could spell end to fillings'
http://www.telegraph.co.uk/health/healthnews/7914009/Gel-for-decayed-teeth-could-spell-end-to-fillings.html

More than half animal tests use GM species
http://www.telegraph.co.uk/science/science-news/7913646/More-than-half-animal-tests-use-GM-species.html

U.S. farmers urge sanctions against EU's GM crop ban
http://in.reuters.com/article/idINIndia-50441920100727

FDA gives priority to Merck KGaA's MS pill
http://www.pharmatimes.com/WorldNews/article.aspx?id=18271

Banned cancer drugs to be paid for with £50m government fund
http://www.telegraph.co.uk/health/healthnews/7912228/Banned-cancer-drugs-to-be-paid-for-with-50m-government-fund.html

UK lags Europe in uptake of new cancer drugs, study shows
http://www.pharmatimes.com/WorldNews/article.aspx?id=18268

Allos' cancer drug extends lung cancer survival
http://www.reuters.com/article/idUSSGE66Q0LS20100728

Man jailed for trying to sell The Ritz
http://web.orange.co.uk/article/news/Man_jailed_for_trying_to_sell_The_Ritz


Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

At any time, you can amend your subscriptions with Gowlings by visiting our website (subscribe | unsubscribe). By your use of this service you agree to the Terms of Use. If you do not agree with the Terms of Use, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.

© 2010 Gowling Lafleur Henderson LLP. All rights reserved.